Benzinga | Mar 24, 2021 09:43AM EDT

From BZ Biotech Conference: AcelRX CEO Vincent Angotti Says Believes That As Elective Surgeries Begin To Ramp In 2H 2021, DSUVIA Is Well Positioned To Help With Patient Throughput

https://www.youtube.com/watch?v=ezt3L9O6KYU&list=PL4k0fH8EgI3bguSp64h2XAlxhf2gkl21A&index=2